Business Context and Reporting Period
Company: AMN Healthcare Services, Inc.
Filing Type: Form 10-K (Annual Report)
Period Ended: December 31, 2002
Business Overview: AMN Healthcare is the largest nationwide provider of travel nurse staffing services in the United States. The company recruits nurses and allied health professionals (93% nurses, 7% allied health) and places them on temporary assignments, typically 13 weeks, at hospitals and healthcare facilities. The company utilizes a multi-brand recruiting strategy with six distinct brands (e.g., American Mobile Healthcare, NursesRx) to attract professionals, while marketing to clients under the single corporate brand AMN Healthcare. As of December 31, 2002, the company served over 3,600 hospital and healthcare facility clients.
Key Financial Metrics
| Metric (in thousands) | 2002 | 2001 |
|---|---|---|
| Revenue | $775,683 | $517,794 |
| Cost of Revenue | $586,900 | $388,284 |
| Gross Profit | $188,783 | $129,510 |
| Gross Margin | 24.3% | 25.0% |
| Operating Income | $86,265 | $16,478 |
| Net Income | $52,356 | $(4,386) |
| Diluted EPS | $1.12 | $(0.14) |
| Cash and Cash Equivalents | $40,135 | $15,654 |
| Working Capital | $137,305 | $116,478 |
| Total Debt | $0 | $0 |
| Goodwill | $135,532 | $127,752 |
Operational Metrics: Average temporary healthcare professionals on assignment increased to 7,783 in 2002 from 5,964 in 2001. Approximately 96% of contracts were payroll contracts, where the company employs the professionals and bills the client an hourly rate.
Material Changes vs. Prior Period
- Revenue Growth: Revenue increased 50% to $775.7 million. Approximately 45% of this growth was organic, driven by a 26% increase in the number of professionals on assignment and enhancements in contract terms (higher hourly rates). The remaining growth was attributable to the acquisitions of O'Grady-Peyton International (OGP) and Healthcare Resource Management Corporation (HRMC).
- Profitability: The company transitioned from a net loss of $4.4 million in 2001 to a net income of $52.4 million in 2002. This significant improvement was driven by organic growth, the elimination of non-cash stock-based compensation charges (which dropped from $31.9 million in 2001 to $0.9 million in 2002), and the absence of interest expense following the retirement of all debt in late 2001.
- Goodwill Accounting: The company adopted SFAS No. 142 in 2002, ceasing the amortization of goodwill. Consequently, amortization expense dropped from $5.6 million in 2001 to $0.4 million in 2002 (related only to other intangibles).
- Stock Repurchases: In 2002, the company repurchased 2,078,100 shares of common stock for an aggregate of $35.2 million under a $100 million authorization program.
Guidance, Outlook, Risks, and Unusual Items
Outlook and Management Commentary: Management noted that while the industry experienced accelerated growth from 2000 to 2002, the growth rate has "substantially moderated" in recent quarters. Hospitals are placing orders later in the placement cycle and maximizing the utilization of permanent staff. Despite this moderation, the company expects cash generated from operations and available borrowings to be sufficient to fund operations for the next 12 months.
Key Risks and Contingencies:
- Nursing Shortage: The company relies on its ability to attract and retain qualified nurses. A shortage of nurses and increased competition for talent could increase operating costs and negatively impact business.
- Client Concentration and Contracts: The company does not have long-term exclusive contracts with clients. Demand is sensitive to hospital patient occupancy rates and seasonal fluctuations.
- Goodwill Impairment: With $135.5 million in goodwill (39% of total assets), future impairment charges could materially decrease earnings.
- Regulatory Environment: Changes in healthcare regulations, such as minimum nurse-to-patient ratios or limitations on mandatory overtime, could impact demand. Additionally, healthcare reform efforts could reduce hospital spending on staffing.
- Legal Liability: The company faces potential liability from medical malpractice claims involving its temporary professionals and employment-related claims.
Unusual Items:
- 2001 Comparison: The 2001 results were significantly impacted by a $31.9 million non-cash stock-based compensation charge related to the vesting of options upon the IPO, and a $5.5 million extraordinary loss on the extinguishment of debt. These items were not present in 2002.
Investor Verification Checklist
- Revenue Quality: Verify the sustainability of the 50% revenue growth given management's commentary on moderating industry growth rates and later order placement cycles.
- Goodwill Valuation: Assess the $135.5 million goodwill balance and the company's annual impairment testing methodology under SFAS No. 142.
- Debt Capacity: Confirm the status of the $75 million revolving credit facility (amended in Jan 2003) and the company's leverage ratios, noting the current debt-free status.
- Stock-Based Compensation: Review the pro forma net income under SFAS No. 123, which would reduce 2002 net income by approximately $1.5 million due to fair value accounting for stock options.
- Acquisition Integration: Monitor the integration of recent acquisitions (HRMC and OGP) and the realization of projected synergies.